Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Alembic Pharmaceuticals Ltd Financial Statements & Historical Data

Updated NSE: APLLTDBSE: 533573
Report details
Last Updated:
Author: |Social: XLinkedIn
COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 2 October 2026, 8:06 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price815₹ per share
Reported P/E21.5Times
Book value per share289₹ per share
Reported ROCE12.6 %%
Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Stored market and accounting figures

Price record: 2 October 2026, 8:06 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap16,025 Cr.
Current Price815
High / Low998/635
Stock P/E21.5
Book Value289
Dividend Yield1.47 %
ROCE12.6 %
ROE13.4 %
Face Value2.00

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Alembic Pharmaceuticals Ltd 16,025 Cr. 815 998/63521.5 2891.47 %12.6 %13.4 % 2.00
Natco Pharma Ltd 16,111 Cr. 821 1,217/78614.1 4700.61 %17.4 %17.1 % 2.00
Jubilant Pharmova Ltd 15,919 Cr. 999 1,185/78441.0 4450.50 %8.99 %6.53 % 1.00
ERIS Lifesciences Ltd 16,507 Cr. 1,190 1,740/1,16325.2 2820.61 %14.1 %18.7 % 1.00
Astrazeneca Pharma India Ltd 15,078 Cr. 6,031 9,850/5,97886.9 3490.60 %29.3 %23.3 % 2.00
Industry Average17,573.63 Cr1,250.1655.08211.240.39%26.16%16.59%6.06

All Competitor Stocks of Alembic Pharmaceuticals Ltd

FINANCIALS

Quarterly performance

Compare sales, expenses, operating profit and net profit on one chart, across the same reporting quarters.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 1,4861,5951,6311,5171,5621,6481,6931,7701,7111,9101,8761,8482,150
Expenses 1,2871,3871,3641,2571,3251,4091,4331,4981,4301,5941,5851,6201,818
Operating Profit 199208266260237239260271281316292228332
OPM % 13%13%16%17%15%15%15%15%16%17%16%12%15%
Other Income 121034230101468-27215
Interest 14161511131922252424232328
Depreciation 66686969697170697476808998
Profit before tax 130135185183157180178192190224162119222
Tax % 7%-1%2%3%14%15%23%18%19%18%18%-70%22%
Net Profit 121137180178135153138157154184132202172
EPS in Rs 6.146.959.189.076.857.807.047.987.859.406.7610.318.80

Last Updated: September 30, 2026, 12:40 am

FINANCIALS

Annual performance

Compare sales, expenses, operating profit and net profit across financial years. Trailing figures remain in the table.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: September 26, 2026, 10:08 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 1,8632,0563,1663,1053,1313,9354,6065,3935,3065,6536,2296,6727,3457,784
Expenses 1,5061,6532,1592,4902,4883,0613,3833,9134,4324,9705,2965,6646,2246,617
Operating Profit 3584031,0076156438741,2231,4808746829321,0081,1211,167
OPM % 19%20%32%20%21%22%27%27%16%12%15%15%15%15%
Other Income 447279-398756-22856-14-1
Interest 104553182716185056799498
Depreciation 40447283105115157183287275273279319342
Profit before tax 3113599365295417491,0001,368625355632707694726
Tax % 24%21%23%23%22%21%20%19%17%4%3%18%3%
Net Profit 2362837204034135838011,146521342616582671690
EPS in Rs 12.4915.0138.2021.3921.8931.0043.9758.3326.5017.4031.3329.6834.3335.27
Dividend Payout % 24%23%9%19%18%18%23%24%38%46%35%37%35%

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)19.92%154.42%-44.03%2.48%41.16%37.39%43.07%-54.54%-34.36%80.12%-5.52%15.29%
Change in YoY Net Profit Growth (%)0.00%134.50%-198.44%46.51%38.68%-3.77%5.68%-97.61%20.18%114.47%-85.64%20.81%

Alembic Pharmaceuticals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 12 years from 2014-2015 to 2025-2026.

Growth

Compounded Sales Growth
10 Years:12%
5 Years:8%
3 Years:8%
TTM:8%
Compounded Profit Growth
10 Years:7%
5 Years:-8%
3 Years:3%
TTM:-6%
Stock Price CAGR
10 Years:4%
5 Years:1%
3 Years:14%
1 Year:-14%
Return on Equity
10 Years:18%
5 Years:13%
3 Years:11%
Last Year:11%

Last Updated: September 4, 2025, 10:45 pm

FINANCIALS

Balance sheet

Compare reserves and borrowings across the same financial years. Reserves are an accounting balance, not available cash.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: August 27, 2026, 4:00 am

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 383838383838393939393939
Reserves 8471,5601,8652,1822,6813,1825,0285,1984,3314,7795,1525,636
Borrowings 264114897081,1281,7475847177225131,2581,430
Other Liabilities 4937186981,0139311,0221,0581,1671,0901,1141,3251,658
Total Liabilities 1,6412,4292,6893,9414,7785,9896,7097,1226,1836,4467,7738,763
Fixed Assets 5477087999931,1581,5521,7881,7982,3982,5472,5243,081
CWIP 83933961,0101,5511,8462,1832,304601524837683
Investments 287504249182361189693127141
Other Assets 1,0091,5411,4441,8962,0192,5732,5022,9023,0873,2814,2854,858
Total Assets 1,6412,4292,6893,9414,7785,9896,7097,1226,1836,4467,7738,763
FINANCIALS

Cash generation

Compare operating cash and free cash flow across reported periods. Negative values remain visible.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 1729483293128124491,46355272480388783
Cash from Investing Activity + -256-307-486-884-756-731-840-372-448-321-568-506
Cash from Financing Activity + 87-224-12950359155-597-217-262-438444-164
Net Cash Flow 3417-286-69115-12726-371445-37113
Free Cash Flow -52647348-49549-285804128282487-466290
CFO/OP 60%114%73%70%112%56%115%77%115%88%16%79%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow-52.00647.00348.00-495.0049.00-285.00804.00128.00282.00487.00-466.00290.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Financial efficiency feed. Source: www.screener.in. The source URL identifies consolidated accounts. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Compare collection, inventory, payment and working-capital cycles together in days. Returns on capital and equity follow in a separate percentage chart.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Returns on capital & equity

%

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 546440406145692456686077
Inventory Days 159196266269302356417431406315350466
Days Payable 148166264213313237220194178145157179
Cash Conversion Cycle 6594429651164266261283237253363
Working Capital Days 453236616924507374778887
ROCE %44%38%66%29%22%23%24%26%11%7%13%13%
FINANCIALS

Ownership trends

Compare ownership groups across the same reporting dates. Shareholder counts appear separately below.

Shareholding comparison

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 69.61%69.61%69.61%69.61%69.61%69.61%69.67%69.68%69.74%69.74%69.74%69.87%
FIIs 4.51%4.52%4.46%4.32%3.94%4.17%3.94%3.96%4.04%4.23%4.26%4.17%
DIIs 14.22%14.51%15.39%15.47%16.05%16.05%16.43%16.46%16.30%16.17%16.17%15.93%
Public 11.67%11.36%10.54%10.61%10.38%10.17%9.96%9.91%9.92%9.84%9.83%10.00%
No. of Shareholders 89,55285,21276,56774,82991,42993,94491,33689,01389,96987,00086,43286,796
Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Kotak Small Cap Fund 3,427,766 1.64 268.46N/AN/AN/A
DSP Mid Cap Fund 2,122,883 0.87 166.262,129,8892025-12-15 00:56:17-0.33%
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund 1,523,120 1.79 119.291,443,3862026-02-20 08:10:255.52%
DSP Small Cap Fund 1,500,000 0.73 117.481,409,0912025-12-08 05:15:136.45%
Axis Small Cap Fund 1,455,416 0.45 113.99N/AN/AN/A
DSP ELSS Tax Saver Fund 1,434,898 0.65 112.381,252,6672025-12-08 05:15:1314.55%
DSP Healthcare Fund 1,428,180 3.76 111.861,423,5632025-12-08 05:15:130.32%
DSP Aggressive Hybrid Fund 810,789 0.54 63.5N/AN/AN/A
DSP Large Cap Fund 608,603 0.67 47.67N/AN/AN/A
ICICI Prudential Smallcap Fund 511,206 0.49 40.04477,1052026-02-21 21:53:207.15%

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Distributions & retention

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 2.002.002.002.002.00
Basic EPS (Rs.) 29.6831.3317.4026.5060.81
Diluted EPS (Rs.) 29.6831.3317.4026.5060.81
Cash EPS (Rs.) 43.7445.2532.9940.8366.05
Book Value[Excl.RevalReserv]/Share (Rs.) 264.10245.14222.36266.47257.80
Book Value[Incl.RevalReserv]/Share (Rs.) 264.10245.14222.36266.47257.80
Revenue From Operations / Share (Rs.) 339.46316.90287.59269.95274.39
PBDIT / Share (Rs.) 53.4648.9336.1847.0479.75
PBIT / Share (Rs.) 39.2935.0522.1732.4570.42
PBT / Share (Rs.) 35.9432.2019.6131.5569.60
Net Profit / Share (Rs.) 29.5731.3818.9726.2356.72
NP After MI And SOA / Share (Rs.) 29.6831.3317.4026.5059.94
PBDIT Margin (%) 15.7415.4312.5817.4229.06
PBIT Margin (%) 11.5711.067.7012.0225.66
PBT Margin (%) 10.5810.156.8211.6825.36
Net Profit Margin (%) 8.719.906.599.7120.67
NP After MI And SOA Margin (%) 8.749.886.059.8121.84
Return on Networth / Equity (%) 11.2312.787.829.9422.97
Return on Capital Employeed (%) 14.4013.809.5811.7925.49
Return On Assets (%) 7.509.555.537.3117.56
Long Term Debt / Equity (X) 0.000.000.000.000.03
Total Debt / Equity (X) 0.230.080.140.120.03
Asset Turnover Ratio (%) 0.930.980.770.730.79
Current Ratio (X) 1.692.121.781.672.01
Quick Ratio (X) 0.740.980.870.720.85
Inventory Turnover Ratio (X) 3.390.890.860.780.93
Dividend Payout Ratio (NP) (%) 37.0625.5357.4752.820.00
Dividend Payout Ratio (CP) (%) 25.0817.6931.8334.060.00
Earning Retention Ratio (%) 62.9474.4742.5347.180.00
Cash Earning Retention Ratio (%) 74.9282.3168.1765.940.00
Interest Coverage Ratio (X) 13.3417.1114.1752.1597.85
Interest Coverage Ratio (Post Tax) (X) 8.2111.988.4330.0870.59
Enterprise Value (Cr.) 19368.4619611.9710301.5015131.7919003.45
EV / Net Operating Revenue (X) 2.903.151.822.853.52
EV / EBITDA (X) 18.4320.3914.4916.3712.12
MarketCap / Net Operating Revenue (X) 2.743.101.722.753.52
Retention Ratios (%) 62.9374.4642.5247.170.00
Price / BV (X) 3.524.012.232.783.70
Price / Net Operating Revenue (X) 2.743.101.722.753.52
EarningsYield 0.030.030.030.030.06
Advertisements
Explore Industry-wise Company financial data